Mitochondrial respiration supports autophagy to provide stress resistance during quiescence

Mitochondrial oxidative phosphorylation (OXPHOS) generates ATP, but OXPHOS also supports biosynthesis during proliferation. In contrast, the role of OXPHOS during quiescence, beyond ATP production, is not well understood. Using mouse models of inducible OXPHOS deficiency in all cell types or specifi...

Full description

Saved in:
Bibliographic Details
Published inAutophagy Vol. 18; no. 10; pp. 2409 - 2426
Main Authors Magalhaes-Novais, Silvia, Blecha, Jan, Naraine, Ravindra, Mikesova, Jana, Abaffy, Pavel, Pecinova, Alena, Milosevic, Mirko, Bohuslavova, Romana, Prochazka, Jan, Khan, Shawez, Novotna, Eliska, Sindelka, Radek, Machan, Radek, Dewerchin, Mieke, Vlcak, Erik, Kalucka, Joanna, Stemberkova Hubackova, Sona, Benda, Ales, Goveia, Jermaine, Mracek, Tomas, Barinka, Cyril, Carmeliet, Peter, Neuzil, Jiri, Rohlenova, Katerina, Rohlena, Jakub
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 03.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mitochondrial oxidative phosphorylation (OXPHOS) generates ATP, but OXPHOS also supports biosynthesis during proliferation. In contrast, the role of OXPHOS during quiescence, beyond ATP production, is not well understood. Using mouse models of inducible OXPHOS deficiency in all cell types or specifically in the vascular endothelium that negligibly relies on OXPHOS-derived ATP, we show that selectively during quiescence OXPHOS provides oxidative stress resistance by supporting macroautophagy/autophagy. Mechanistically, OXPHOS constitutively generates low levels of endogenous ROS that induce autophagy via attenuation of ATG4B activity, which provides protection from ROS insult. Physiologically, the OXPHOS-autophagy system (i) protects healthy tissue from toxicity of ROS-based anticancer therapy, and (ii) provides ROS resistance in the endothelium, ameliorating systemic LPS-induced inflammation as well as inflammatory bowel disease. Hence, cells acquired mitochondria during evolution to profit from oxidative metabolism, but also built in an autophagy-based ROS-induced protective mechanism to guard against oxidative stress associated with OXPHOS function during quiescence. Abbreviations: AMPK: AMP-activated protein kinase; AOX: alternative oxidase; Baf A: bafilomycin A 1 ; CI, respiratory complexes I; DCF-DA: 2′,7′-dichlordihydrofluorescein diacetate; DHE: dihydroethidium; DSS: dextran sodium sulfate; ΔΨmi: mitochondrial inner membrane potential; EdU: 5-ethynyl-2'-deoxyuridine; ETC: electron transport chain; FA: formaldehyde; HUVEC; human umbilical cord endothelial cells; IBD: inflammatory bowel disease; LC3B: microtubule associated protein 1 light chain 3 beta; LPS: lipopolysaccharide; MEFs: mouse embryonic fibroblasts; MTORC1: mechanistic target of rapamycin kinase complex 1; mtDNA: mitochondrial DNA; NAC: N-acetyl cysteine; OXPHOS: oxidative phosphorylation; PCs: proliferating cells; PE: phosphatidylethanolamine; PEITC: phenethyl isothiocyanate; QCs: quiescent cells; ROS: reactive oxygen species; PLA2: phospholipase A2, WB: western blot.
Bibliography:Present address: National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark
ISSN:1554-8627
1554-8635
DOI:10.1080/15548627.2022.2038898